This application is a National Stage Application of International Patent Application No. PCT/US2013/072846, filed Dec. 3, 2013, which claims benefit of U.S. Provisional Application No. 61/732,783, filed Dec. 3, 2012, which applications are incorporated herein by reference. To the extent appropriate, a claim of priority is made to each of the above disclosed applications.
The present disclosure relates generally to sensors. More particularly, the present disclosure relates to sensors for measuring bio-analyte concentrations in blood samples.
Electrochemical bio-sensors have been developed for sensing (e.g., detecting or measuring) bio-analyte concentrations in fluid samples. For example, U.S. Pat. Nos. 5,264,105; 5,356,786; 5,262,035; 5,320,725; and 6,464,849, which are hereby incorporated by reference in their entireties, disclose wired enzyme sensors for sensing analytes, such as lactate or glucose. Wired enzyme sensors have been widely used in blood glucose monitoring systems adapted for home use by diabetics to allow blood glucose levels to be closely monitored. Other example types of blood glucose monitoring systems are disclosed by U.S. Pat. Nos. 5,575,403; 6,379,317; and 6,893,545.
In general terms, this disclosure is directed to a sensor and a method of using the same.
One aspect of the present disclosure relates to a sensor module that includes a carrier and a skin piecing member carried by the carrier. The skin piercing member has a skin piecing end positioned opposite from a base end. The skin piecing member defines a lumen that extends along the central longitudinal axis from the skin piercing end toward the base end where the lumen has a lumen axis. The sensor module includes a blood sample analysis zone located entirely within the lumen of the skin piercing member and a capillary flow stop for stopping capillary flow at a predetermined location within the lumen of the skin piercing member. The sensor module further includes an elongated working electrode positioned within the lumen. The working electrode has a length that extends along the lumen axis where at least a section of the working electrode is positioned within the analysis zone and the working electrode includes sensing chemistry.
Another aspect of the present disclosure relates to a sensor module including a carrier and a skin piecing member carried by the carrier. The skin piercing member has a skin piecing end positioned opposite from a base end. The skin piecing member defines a lumen that extends along the central longitudinal axis from the skin piercing end toward the base end and the lumen defines a lumen axis. The sensor module includes a blood sample analysis zone located within the lumen of the skin piercing member and an elongated working electrode positioned within the lumen. The working electrode having a length that extends along the lumen axis, at least a section of the working electrode is positioned within the analysis zone and the working electrode includes sensing chemistry. The working electrode has an end within 0.5 millimeters of a tip of the skin piercing member.
A further aspect of the present disclosure relates to a sensor module including a carrier movable relative to a base between a first position and second position and a skin piecing member carried by the carrier. The skin piercing member has a skin piecing end positioned opposite from a base end and the skin piercing member defines a lumen that extends along the central longitudinal axis from the skin piercing end toward the base end. The lumen defines a lumen axis. The sensor module includes a blood sample analysis zone located entirely within the lumen of the skin piercing member and an elongated working electrode positioned within the lumen. The working electrode has a length that extends along the lumen axis where at least a section of the working electrode is positioned within the analysis zone and the working electrode has sensing chemistry.
A further aspect of the present disclosure relates to a sensor module that includes a carrier and a skin piercing member carried by the carrier. The skin piercing member has a skin piercing end positioned opposite from a base end and the skin piercing member defines a lumen that extends along the central longitudinal axis from the skin piercing end toward the base end. The lumen defines a lumen axis. The sensor module includes a blood sample analysis zone located within the lumen of the skin piercing member and an elongated working electrode positioned within the lumen. The working electrode has a length that extends along the lumen axis where at least a section of the working electrode is positioned within the analysis zone. The working electrode includes sensing chemistry and is formed by a single fiber or wire.
A further aspect of the present disclosure relates to a method for taking a blood analyte reading that includes puncturing skin with a skin piercing member having a lumen and positioning a tip of the skin piercing member in a capillary blood field less than 3 millimeters beneath the skin. The method includes initiating blood flow into the lumen by a combination of vascular blood pressure and capillary action to passively bring a blood sample to an analysis zone entirely within the lumen and sensing the blood analyte in the analysis zone.
Still another aspect of the present disclosure relates to a device for sensing an analyte in a blood sample. The device includes an elongated working electrode having a first portion that is subcutaneous during testing and a second portion that extends outside the body during testing. The device is configured for a one time use in which one analyte reading is taken.
Another aspect of the present disclosure relates to a device for sensing an analyte in a blood sample. The device includes a working electrode formed by a single conductive fiber or wire having a first portion that is subcutaneous during testing and a second portion that extends outside the body during testing. The working electrode includes a layer of sensing chemistry on the first and second portions of the conductive fiber or wire.
A further aspect of the present disclosure relates to a device for sensing an analyte in a blood sample. The device includes a working electrode formed by a conductive fiber or wire having a first portion that is subcutaneous during testing and a second portion that extends outside the body during testing. The working electrode includes a layer of sensing chemistry on the first and second portions of the conductive fiber or wire. The device further includes a skin piercing member having a lumen in which the working electrode is positioned. The conductive fiber or wire has an outer diameter that is at least 10 percent as large as an outer diameter of the skin piercing member.
A further aspect of the present disclosure relates to a device for sensing an analyte in a blood sample. The device includes a working electrode formed by a conductive fiber or wire having a first portion that is subcutaneous during testing and a second portion that extends outside the body during testing. The working electrode includes a layer of sensing chemistry on the first and second portions of the conductive fiber or wire. The device includes a skin piercing member having a lumen in which the working electrode is positioned. The conductive fiber or wire has an outer diameter that is greater than 0.001 inches.
Another aspect of the present disclosure relates to a device for sensing an analyte in a blood sample. The device includes an elongated working electrode including a conductive fiber or wire having a first portion that is subcutaneous during testing and a second portion that extends outside the body during testing. The conductive fiber or wire has a cross-dimension greater than 0.001 inches.
Still another aspect of the present disclosure relates to a device for sensing an analyte in a blood sample. The device includes a working electrode formed by a conductive fiber or wire having a first portion that is subcutaneous during testing and a second portion that extends outside the body during testing. The working electrode includes a layer of sensing chemistry on the first and second portions of the conductive fiber or wire. The device further includes a skin piercing member having a lumen in which the working electrode is positioned. The device is configured such that a blood analysis zone of the device fills passively.
A variety of additional aspects will be set forth within the description that follows. The aspects can relate to individual features and to combinations of features. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the broad concepts upon which the embodiments disclosed herein are based.
Various embodiments will be described in detail with reference to the drawings, wherein like reference numerals represent like parts and assemblies throughout the several views. Reference to various embodiments does not limit the scope of the claims attached hereto. Additionally, any examples set forth in this specification are not intended to be limiting and merely set forth some of the many possible embodiments for the appended claims.
The following definitions are provided for terms used herein:
A “working electrode” is an electrode at which the analyte (or a second compound whose level depends on the level of the analyte) is electrooxidized or electroreduced with or without the agency of an electron transfer agent.
A “reference electrode” is an electrode used in measuring the potential of the working electrode. The reference electrode should have a generally constant electrochemical potential as long as no current flows through it. As used herein, the term “reference electrode” includes pseudo-reference electrodes. In the context of the disclosure, the term “reference electrode” can include reference electrodes which also function as counter electrodes (i.e., a counter/reference electrode).
A “counter electrode” refers to an electrode paired with a working electrode to form an electrochemical cell. In use, electrical current passes through the working and counter electrodes. The electrical current passing through the counter electrode is equal in magnitude and opposite in sign to the current passing through the working electrode. In the context of the disclosure, the term “counter electrode” can include counter electrodes which also function as reference electrodes (i.e., a counter/reference electrode).
A “counter/reference electrode” is an electrode that functions as both a counter electrode and a reference electrode.
An “electrochemical sensing system” is a system configured to detect the presence and/or measure the level of an analyte in a sample via electrochemical oxidation and reduction reactions on the sensor. These reactions are converted (e.g., transduced) to an electrical signal that can be correlated to an amount, concentration, or level of an analyte in the sample. Further details about electrochemical sensing systems, working electrodes, counter electrodes and reference electrodes can be found at U.S. Pat. No. 6,560,471, the disclosure of which is hereby incorporated herein by reference in its entirety.
“Electrolysis” is the electrooxidation or electroreduction of a compound either directly at an electrode or via one or more electron transfer agents.
An “electron transfer agent” is a compound that carries electrons between the analyte and the working electrode either directly or in cooperation with other electron transfer agents. One example of an electron transfer agent is a redox mediator.
A “sensing layer” is a component of the sensor which includes constituents that facilitate the electrolysis of the analyte. The sensing layer may include constituents such as an electron transfer agent, a catalyst which catalyzes a reaction of the analyte to produce a response at the electrode, or both.
The carrier member 102 is arranged and configured to slideably move along the base 104 within opposite channels 108 defined by the base 104. The channels 108 of the base 104 limit upward or downward movement of the carrier 102 relative to the base 104. The carrier 102 defines a first cavity 116 to mount the skin piercing member 110. In one example, the piercing member 40 is fixed relative to the carrier 102 such that the piercing member 40 is carried by the carrier 102 as the carrier 102 slides relative to the base 104. The carrier 102 is illustrated and described in more detail with reference to
The skin piercing member 110 extends along a length L of the carrier 102. The skin piercing member 110 is movable with the carrier 102 between a retracted position and an extended position (see
The electrical contacts 112, 114 mount on the carrier 102. The contacts 112, 114 respectively have contact tabs 120, 122. Tab 120 can be used to electrically connect the contact 112 to a reference electrode provided on an exterior surface of the member 110. Tab 122 can be used to electrically connect the contact 114 to a working electrode having a portion that extends into the piercing member 110 and a portion that extends axially outwardly from a base end of the piercing member 110. The contacts 112, 114 can include structures for electrically connecting the sensor module 100 to a sensor control system. In one example, the sensor control system applies a voltage across the working and reference electrodes and through a blood sample contained within a lumen of the skin piercing member 110. The reference electrode can be formed as a conductive layer provided on the outer surface of the skin piercing member 110. The electrical contacts 112, 114 are illustrated and described in more detail with reference to
In one example, the skin piercing member 110 is hollow and defines an interior lumen in which a working electrode is positioned. The working electrode can be formed by a conductive fiber or wire. A sensing layer can cover the conductive fiber or wire. A portion of the conductive fiber or wire covered with the sensing layer can form a sensing region located within a sample analysis zone contained entirely within the skin piercing member. The sample analysis zone 130 can provide for specific control of interrelated parameters such as active electrode area, response time, sensitivity, and drift to be engineered in as byproducts of static component features.
In use, the skin piercing member is inserted into the skin to a depth less than 3 millimeters such that the tip 138 resides in the capillary bed. As so positioned, a first portion of the working electrode is subcutaneous and a second portion extends outside the body beyond the skin. Upon insertion, the combination of vascular pressure and capillary action causes blood to rapidly fill the lumen 144 and surround the portion of the working electrode within the skin piercing member 110. The blood flows up the lumen to the capillary stop. The volume of space defined within the skin piercing member from the tip to the capillary stop forms an analysis zone having a length that corresponds to a length of a wetted surface area of the sensing chemistry supported on the conductive fiber or wire of the working electrode. The capillary stop combined ensures that the wetted surface area is precisely controlled (i.e., the wetted length of sensor chemistry corresponds to the length of the working electrode that extends below the capillary stop). Applying a voltage between reference and working electrodes causes the oxidation/reduction of glucose in the analysis zone thereby generating a current at the working electrode which can be measured to sense a concentration of glucose in the blood sample. Control circuitry can apply the voltage, measure the current, and provide a display showing a reading indicating the glucose level.
The sensor module 100 is relatively compact and disposable. For example, the sensor module 100 is generally rectangular in shape and has a length that is less than 1 inch. The sensor module 100 includes opposite major sides and opposite minor sides that extend along the length of the sensor module 100.
The skin piercing member 110 of the sensor module 100 includes a skin piercing end 136 having a sharp tip 138 and a base end 140. The tip 138 of the skin piercing member 100 penetrates the skin of a patient and can be configured to provide a cutting action that generates a wound that self-closes upon removal of the piercing member 110 from the skin. The skin piercing member 110 can be a cannula, needle, or other similar structure preferably having a hollow interior. In this example, the sensor is configured to allow the analysis of the fluid sample to take place entirely within the skin piercing member 110. The skin piercing member 110 provides a volume or reservoir 107 for collecting blood received from a skin puncture site caused by the skin piercing member 110.
In one example, the skin piercing member 110 has a non-conductive construction. An example of a non-conductive construction includes a conductive base metal body (for strength) encased within a dielectric layer. The skin piercing member 110 includes a metal body 109 (
In use of the sensor module 100, a contact end 124 of the base 104 is placed against a patient's skin at a sampling site where it is desired to take a fluid (e.g., blood) sample. Once the contact end 124 is in contact with the skin, the skin piercing member 110 is moved from the retracted position to the extended position (e.g., by sliding the carrier 102 relative to the base 104) thereby causing the tip 136 of the skin piercing member 110 to pierce the patient's skin. Upon insertion of the skin piercing member 110, blood from the capillary field fills the skin piercing member 110. Blood flow is caused at least in part by vascular pressure within the capillary bed. Capillary action also moves blood upwardly within the piercing member 110 to fill a sample analysis zone 130 within the piercing member 110. At the sample analysis zone 130, an analyte level (e.g., blood glucose level) in the blood sample is sensed through the use of a wired enzyme sensor arrangement including an elongated working electrode (WE) 142 (
In some embodiments, a test is initiated by pressing an actuator button (not shown) on top of a meter (not shown) while holding the sensor module 100 on the test site (i.e., forearm or fingertip). This action causes a sequence of motions moving the sensor module 100 from a position within the sensor module 100 to an opening in the bottom of the meter. The meter can be placed on the approved testing site, (i.e., forearm or finger). The actuator button can be pressed again following a prompt causing the carrier 102 of the sensor module 100 carrying the skin piercing member 110 to move rapidly forward inserting the skin piercing member 110 to a prescribed depth. The skin piercing member 110 of the sensor module 100 enters a depth in tissue where a capillary blood field is encountered. The skin piercing member 110 stops at a capillary depth of about less than 3 mm below the skin surface and can reside for about less than 3 seconds to acquire a blood sample. The sample can be presented to the sensor module 100 by a rapid microfluidic flow initiated automatically by a combination of vascular blood pressure and capillary action. The sensor module 100 requires no other active mechanism to obtain a blood glucose value resulting in a passive system. Once the test is performed or completed, the carrier can be disposed by the user.
In one embodiment, the working electrode can include an elongated member that is coated or otherwise covered with a sensing layer and the reference/counter electrode can include any elongated member, such as a wire or fiber that is coated or otherwise covered with a layer, such as silver chloride. Preferably, at least a portion of each elongated member is electrically conductive. In certain embodiments, each elongated member can include a metal wire or a glassy carbon fiber. In still other embodiments, each elongated member can each have a composite structure and can include a fiber having a dielectric core surrounded by a conductive layer suitable for forming an electrode. The core can be made of medical grade polyetheretherketone.
An example composite fiber is sold under the name Resistat® by Shakespeare Conductive Fibers LLC. This composite fiber includes a composite nylon, monofilament, conductive thread material made conductive by the suffusion of about a 1 micron layer of carbonized nylon isomer onto a dielectric nylon core material. The Resistat® material is comprised of isomers of nylon to create the basic 2 layer composite thread. However, many other polymers are available for the construction, such as: polyethylene terephthalate, nylon 6, nylon 6,6, cellulose, polypropylene cellulose acetate, polyacrylonitrile and copolymers of polyacrylonitrile for a first component and polymers such as of polyethylene terephthalate, nylon 6, nylon 6,6, cellulose, polypropylene cellulose acetate, polyacrylonitrile and copolymers of polyacrylonitrile as constituents of a second component. Inherently conductive polymers (ICP) such as doped polyanaline or polypyrolle can be incorporated into the conductive layer along with the carbon to complete the formulation. In certain embodiments, the ICP can be used as the electrode surface alone or in conjunction with carbon. The Resistat® fiber is availability in diameters of 0.0025 to 0.016 inches, which is suitable for sensor electrodes configured in accordance with the principles of the present disclosure. Example patents disclosing composite fibers suitable for use in practicing sensor modules configured in accordance with the principles of the present disclosure include U.S. Pat. Nos. 3,823,035; 4,255,487; 4,545,835 and 4,704,311, which are hereby incorporated herein by reference in their entireties.
The sensing layers provided at working electrodes of sensor modules configured in accordance with the principles of the present disclosure can include a sensing chemistry, such as a redox compound or mediator. The term redox compound is used herein to mean a compound that can be oxidized or reduced. Example redox compounds include transition metal complexes with organic ligands. Preferred redox compounds/mediators include osmium transition metal complexes with one or more ligands having a nitrogen containing heterocycle such as 2,2′-bipyridine. The sensing material also can include a redox enzyme. A redox enzyme is an enzyme that catalyzes an oxidation or reduction of an analyte. For example, a glucose oxidase or glucose dehydrogenase can be used when the analyte is glucose. Also, a lactate oxidase or lactate dehydrogenase fills this role when the analyte is lactate. In sensor systems, such as the one being described, these enzymes catalyze the electrolysis of an analyte by transferring electrons between the analyte and the electrode via the redox compound. Further information regarding sensing chemistry can be found at U.S. Pat. Nos. 5,264,105; 5,356,786; 5,262,035; and 5,320,725, which were previously incorporated by reference in their entireties.
In one embodiment, the skin piercing member 110 defines a lumen 144 that extends along an elongated axis 10 from the skin piercing end 136 of the skin piercing member 110 toward the base end 140. The elongated working electrode 142 is positioned within the lumen 144. The elongated working electrode 142 has a length that extends along the lumen axis 20 and at least a section of the elongated working electrode 142 is positioned within the sample analysis zone 130. The elongated working electrode 142 includes the sensing chemistry.
The interaction of the skin piercing member 110 in concert with microfluidic forces (e.g., surface tension) within the lumen 144 promotes capillary flow of blood. Flow is initiated by ambient capillary pressure at the proximal lumen of the skin piercing member 110 when the piercing member is inserted into the papillary dermis to a depth of between 1-2 mm below the skin. Flow may also be promoted by the treatment of the lumen 144 with a surfactant compound. When so prepared, the combined factors create a driving mechanism to enable a spontaneous flow of capillary blood to enter the proximal lumen 144 and fill the skin piercing member 110 throughout its length.
The capillary stop 154 is formed at the skin piercing member 110 to inhibit the spontaneous blood flow from exiting the skin piercing member 110 at the distal end of the lumen 144. The self-limiting action of the flow into the interior passage of the skin piercing member 110 facilitates the lumen 144 to function as both an analysis cell—defined by the volume of the skin piercing member 110 and the length of the wetted working electrode WE portion residing within the skin piercing member 110—and as a counter electrode component of a multi electrode electrochemical cell.
The lumen 144 of the piercing member 110 may be sized appropriately to the configuration of the electrode bundle within it so as to optimize the microfluidic forces affecting the rate of transport thru the passage to the capillary stop 154. The lumen length must extend far enough above the tissue so as to provide sufficient surface area of the working electrode WE to produce a specified minimal output current. However, the lumen length may not be excessive or the time required to fill the lumen will drop rapidly with falling capillary pressure and fluid resistance slowing the transport rate.
The above described configuration of the electrode array within the piercing member 110 allows the major portion of the electrode surface to remain above the skin line presenting only the diameter of the piercing member 110 to the enervated tissue of the papillary dermis. This configuration allows the effective current produced by the electrode within the piercing member 110 to be two orders of magnitude larger than a traditional implanted sensor occupying the same footprint within tissue. In certain examples, the electrodes have an operational radius of less than 0.15 mm and a length of between 10 mm and 20 mm.
Referring to
In this example, the elongated working electrode 142 is positioned within the lumen 144 of the skin piercing member 110 and includes a monofilament 146 (i.e., fiber) that can be coated with a conductive layer 148 (i.e., gold). The monofilament can be a polymeric material such as medical grade polyetheretherketone. The conductive monofilament 146 (fiber or wire) can have an outer diameter that is at least 10 percent as large as an outer diameter of the skin piercing member 110. The conductive layer 148 may be applied as a continuous Plasma Vacuum Deposition (PVD) process. The conductive layer 148 can be less than about 10 microns. The diameters of the multi-fiber composite can be between 0.001 inches and 0.004 inches. In this example, the elongated working electrode 142 may be coated in a secondary process step over the conductive layer 148 with glucose oxidase or other suitable enzyme chemistry. The elongated working electrode 142 may be inserted into the lumen 144 of the skin piercing member 110.
In this example, the skin piercing member 110 can include a conductive reference electrode (RE) layer 150 formed as a thick film of silver/silver chloride (Ag/Ag/Cl) on the insulated outer surface of the skin piercing member 110. The monofilament 146 (i.e., fiber) can be an aluminum conductive composite monofilament (CCM) with an enzyme sensing layer 152 which can serve as the elongated working electrode 142. The sensor module 100 can become active when an ionic fluid such as blood simultaneously contacts both the outer surface of the conductive reference electrode layer 150 (RE) and the elongated working electrode 142 (WE) completing an electrical circuit through the fluid path. Once the circuit is established by a passive process of rapid capillary flow into the lumen 144 of the skin piercing member 110, blood continues up a defined open passage space (less than 0.004 inches circumferential clearance) surrounding the fiber until encountering a capillary stop 154 feature formed at the base end 140 of the piercing member 110. The lumen 144 can be kept partially open at the base end 140 to serve as an air vent to promote the capillary flow.
In this example, the insertion end of the lumen 144 should be free of tissue plugs and reside at or below the vascular plexus (VP) between about 1 to 2 mm deep in the dermal layer where capillary vascular pressure is sufficient (about 14 to 22 mm Hg) to promote initial blood flow into the flow passage 128 of the skin piercing member 110. Capillary flow can augment external vascular pressure to rapidly sweep up the interior of the flow passage 128 to the capillary stop 154. Rapid autonomous and complete filling of the sample analysis zone 130—can be defined by the interior volume 107 of the skin piercing member 110 less the volume of the electrode within a space. This filling can be co-determinant of response time and is promoted by the addition of surfactants such as, but not limited to, Triton materials to either the skin piercing member 100 interior surface or to the detector chemistry or both.
In this example, the sample analysis zone 130 includes a controlled surface area of sensing chemistry that is wetted with blood during testing such that the entire controlled surface area is wetted when the analyte reading is taken. The controlled surface area is at least 10 times as large as a transverse cross-sectional area of the skin piercing member. In other embodiments, the controlled surface area can be at least 20 or 30 times larger than a transverse cross-sectional area of the working electrode.
Automation suitability can create a sensor configuration that will improve both quality of testing and the reliability of the test procedure for the consumer. The analysis zone method described can rely upon interdependent effects of defined part geometry, spatial relationships of components and specific transitional properties of the enzyme detector chemistry as it is hydrated by the incoming blood matrix. These factors in concert with the dynamic interaction of blood flowing into the cell in response to vascular pressure and capillary action function as the analysis zone method for establishing a rapid and self-limiting amperometric assay cell formed along a defined section of a long fiber.
Flow up the lumen 144 of the skin piercing member 110 can be within the microfluidic domain of non-Newtonian laminar flow. This transport dynamic up the circumferential channel 128 defined within the lumen 144 between the working electrode 142 and the inner surface of the skin piercing member 110 can be optimized by promoting low surface energy properties for the WE to allow complete and rapid wetting of the enzyme sensing layer 152. This surface property in turn can act in concert with the laminar flow dynamics to sweep the entire cavity containing the WE, free of air pockets that could otherwise unpredictably affect the area of blood in contact with the electrode surface causing irreproducible sensor performance.
The capillary pressure, the viscosity of the blood media plus the surface energy interactions of the electrode coating and the skin piercing member 110 inner wall surface in concert with the distance separating the surfaces can all impact micro capillary flow characteristics.
The capillary stop 154 can be a mechanism that limits further fluid flow along the enzyme sensing layer 152 forming the WE and provides for venting of air displaced by the rapid filling of the capillary space by blood. In this example, one functional characteristic of the WE is that the dry enzyme detector chemistry can be an effective insulator and can transition in phases from insulator to semiconductor to conductor as it becomes hydrated. This property prevents errant signal contributions to any portion of the CCM fiber kept dry during the time of the glucose assay. By defining the hydrated area of the WE through the combined use of the capillary stop 154 feature with mechanical control of the length of CCM fiber extending down into the skin piercing member passage 134. This method of defining electrode surface area provides for both manufacturing and functional advantages.
Referring again to
In this example, within a few hundredths of a second the defined sample analysis zone 130 is filled and the hydrating WE initiates an exchange electrons with the Ag/AgCl RE pattern on the non-conductive surface of the skin piercing member 110. A rising current appears at the data acquisition input of the sensor module 100 causing the software to start a countdown before initiating a data acquisition sequence for a prescribed number of discrete points (currently 500) taken at intervals over a set time window. The data set can be grouped by taking a mean of the discrete points. An area under the curve analysis can be applied to predict the plateau current for the sensor module 100. The correlation equates to a calibrated number representing a known glucose concentration at that current. The software then stores the value and can display it to the user on the meter LCD. The entire sequence from initiating actuator button to displayed blood glucose value requires less than 5 seconds. The result of the above testing sequence can be considered to be one reading. In certain examples, the modules 100 are single use and each can be used to provide one glucose reading.
In certain embodiments, the data can be acquired using wireless device or portable electronic device (PED) such as, but not limited to, cellular phones. The PED can be used to act as a control unit for the sensor module 100. The sensor module 100 can be configured to interface with the PED which can store and display the glucose concentration to the user. In other embodiments, a separate test unit may be utilized to interface with a wireless device or PED (i.e., cellular phone). A chipset or similar component can be used in a glucose module to link to a PED via a broadband connection. The glucose test module can be connected automatically to the PED to initiate an application that would perform and display all the data management tasks. The glucose test module can be configured to have wide area network (WAN) capability to link to therapeutic software resident on other servers, such as, but not limited to, Cloud, that would completely automate the diabetics provisioning and treatment as well as link to a patient's physician or caregiver in real time. The glucose test module can be about 2.5 inch wide, about 3 inches long and about ¼ inch high.
Referring to
In this example, the three CCM electrodes 200 are arranged and configured such that both RE and WE electrodes 202, 204 may be simultaneously inserted into a lumen of a skin piercing member. The skin piercing member is 29 gauge or smaller. The skin piercing member can have a size between approximately 28 gauge to 30 gauge, preferably a 30 gauge size in the example of home blood glucose testing.
The configuration of the multi-electrode may employ slightly different micro extrusion profiles as carriers for the three CCM electrodes 200, WE and RE fiber electrodes 202, 204. The micro extruded carrier profile is so designed in cross section as to maintain electrical isolation of the RE and WE 202,204—both from each other, and from the stainless steel piercing member (i.e., cannula). In some embodiments, the multi-electrode may have two working electrodes and one RE. The specific properties and profile extrusions 208, 210 (
The multi-electrode configuration allows for the ability to eliminate an Ag/Ag/Cl film coating for the RE 202 and substitute a composite Ag substrate fiber that can be fabricated in the same substrate materials and PVD process as the WE. The multi-electrode configuration can include a third electrode 206 (e.g., a supplemental electrode) that has no need for enzyme or detector chemistry. The third electrode 206 may be employed as a comparison means to determine what portion of the raw sensor current comes from interferent compounds such as vitamin C rather than from glucose. The comparison means can be a result of oxidizing those compounds at the bare Au surface and subtracting the apparent signal from the total sensor output. This function eliminates a developmental step in the electrode design and can help to resolve a common background noise problem for sensor accuracy. In other embodiments, additional electrodes beyond the three electrode profile may be added to the structure for the purpose of multi-parameter assays. Multi-parameter sensors providing more than two analyte targets for use in continuous monitoring can be fabricated. The supplemental electrode can also be used to defect other analytes (e.g., lactate) or to defect oxygen concentration.
Turning to
Referring to
In this example, the two electrodes 400 configuration includes a monofilament 402 (i.e., fiber). The monofilament 402 can be insulated using an insulating substrate layer 404 similar to the embodiments described above. The monofilament 402 is capable of insertion into a lumen 406 of a skin piercing member 408. As shown, an AgAg/Cl layer 410 can be applied directly onto the insulating substrate layer 404.
Referring to
The AgAg/Cl layer 410 can be applied using fixtures and/or masks 412 to direct a plasma deposition of silver (Ag) travelling perpendicular to the plane P of the mask 412 onto a single surface of the profile for forming the RE.
Referring to
In general, the unit 300 includes a controller 302, an actuator 306, and input lines 308. The controller 302 controls the actuator 306 for driving the skin piercing members 110 of each sensor module 100 between the extended and retracted positions to obtain a fluid sample. The controller 302 can include a microcontroller, a mechanical controller, software driven controller, a hardware driven controller, a firmware driven controller, etc. The controller can include a microprocessor that interfaces with memory.
The controller 302 instructs the actuator 306 when to operate the sensor module 100 to obtain a fluid sample for analysis. The controller 302 also can instruct the module holder 304 and/or the actuator 306 to eject the used sensor module 100.
The input lines 308 carry the data/signals/readings (e.g., voltage values) generated at the elongated working electrode 142 of the sensor module 100 during analysis of a fluid sample to the controller 302 for analysis. The controller 302 converts the signals to an analyte concentration level (e.g., a blood glucose reading) or other desired information. The controller 302 causes the display 310 to indicate the processed information to the user. Other information also can be presented on the display 310. In one embodiment, the display 310 is a visual display. In other embodiments, an audio display also can be used. Additional information can be provided to the controller 302 via a user interface 312 (e.g., buttons, switches, etc.).
From the forgoing detailed description, it will be evident that modifications and variations can be made without departing from the spirit and scope of the disclosure.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2013/072846 | 12/3/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2014/089058 | 6/12/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1454224 | Schmidt | May 1923 | A |
2291720 | Hukle | Aug 1942 | A |
3170968 | Rokunohe et al. | Feb 1965 | A |
3766910 | Lake | Oct 1973 | A |
3823035 | Sanders | Jul 1974 | A |
4008717 | Kowarski | Feb 1977 | A |
4073974 | Albarino et al. | Feb 1978 | A |
4224125 | Nakamura et al. | Sep 1980 | A |
4255487 | Sanders | Mar 1981 | A |
4321057 | Buckles | Mar 1982 | A |
4399099 | Buckles | Aug 1983 | A |
4439303 | Cocchi | Mar 1984 | A |
4545283 | Sandberg et al. | Oct 1985 | A |
4545382 | Higgins et al. | Oct 1985 | A |
4545835 | Gusack et al. | Oct 1985 | A |
4552840 | Riffer | Nov 1985 | A |
4573968 | Parker | Mar 1986 | A |
4640821 | Mody et al. | Feb 1987 | A |
4671288 | Gough | Jun 1987 | A |
4704311 | Pickering et al. | Nov 1987 | A |
4734184 | Burleigh et al. | Mar 1988 | A |
4762603 | Morin | Aug 1988 | A |
4805624 | Yao et al. | Feb 1989 | A |
4820399 | Klainer et al. | Apr 1989 | A |
4824206 | Saxena | May 1989 | A |
4833083 | Klainer | Jul 1989 | A |
4846548 | Klainer | Jul 1989 | A |
4880752 | Keck et al. | Nov 1989 | A |
4908115 | Morita et al. | Mar 1990 | A |
4919649 | Timothy et al. | Apr 1990 | A |
4927516 | Yamaguchi et al. | May 1990 | A |
4945896 | Gade | Aug 1990 | A |
4974929 | Curry | Dec 1990 | A |
4981779 | Wagner | Jan 1991 | A |
5001054 | Wagner | Mar 1991 | A |
5002651 | Shaw et al. | Mar 1991 | A |
5004583 | Guruswamy et al. | Apr 1991 | A |
RE33677 | Vazirani | Aug 1991 | E |
5047044 | Smith et al. | Sep 1991 | A |
5112455 | Cozzette et al. | May 1992 | A |
5131138 | Crouse | Jul 1992 | A |
5164229 | Hay et al. | Nov 1992 | A |
5165406 | Wong | Nov 1992 | A |
5165407 | Wilson et al. | Nov 1992 | A |
5171689 | Kawaguri et al. | Dec 1992 | A |
5186808 | Yamaguchi et al. | Feb 1993 | A |
5205920 | Oyama et al. | Apr 1993 | A |
5217533 | Hay et al. | Jun 1993 | A |
5220920 | Gharib | Jun 1993 | A |
5243982 | Möstl et al. | Sep 1993 | A |
5244636 | Walt et al. | Sep 1993 | A |
5250264 | Walt et al. | Oct 1993 | A |
5262035 | Gregg et al. | Nov 1993 | A |
5264092 | Skotheim et al. | Nov 1993 | A |
5264103 | Yoshioka et al. | Nov 1993 | A |
5264104 | Gregg et al. | Nov 1993 | A |
5264105 | Gregg et al. | Nov 1993 | A |
5269891 | Colin | Dec 1993 | A |
5271815 | Wong | Dec 1993 | A |
5271820 | Kinlen et al. | Dec 1993 | A |
5277872 | Bankert et al. | Jan 1994 | A |
5286362 | Hoenes et al. | Feb 1994 | A |
5298144 | Spokane | Mar 1994 | A |
5298741 | Walt et al. | Mar 1994 | A |
5320725 | Gregg et al. | Jun 1994 | A |
5320814 | Walt et al. | Jun 1994 | A |
5330634 | Wong et al. | Jul 1994 | A |
5356786 | Heller et al. | Oct 1994 | A |
5366527 | Amos et al. | Nov 1994 | A |
5372133 | Hogen esch | Dec 1994 | A |
D354347 | Knute et al. | Jan 1995 | S |
D354559 | Knute et al. | Jan 1995 | S |
5384028 | Ito | Jan 1995 | A |
5386828 | Owens et al. | Feb 1995 | A |
5395504 | Saurer et al. | Mar 1995 | A |
5422246 | Koopal et al. | Jun 1995 | A |
5431174 | Knute | Jul 1995 | A |
5437973 | Vadgama et al. | Aug 1995 | A |
5503728 | Kaneko et al. | Apr 1996 | A |
5505828 | Wong et al. | Apr 1996 | A |
5512159 | Yoshioka et al. | Apr 1996 | A |
5515848 | Corbett et al. | May 1996 | A |
5543012 | Watson et al. | Aug 1996 | A |
5575403 | Charlton et al. | Nov 1996 | A |
5591139 | Lin et al. | Jan 1997 | A |
5593852 | Heller et al. | Jan 1997 | A |
5605152 | Slate et al. | Feb 1997 | A |
5609749 | Yamauchi et al. | Mar 1997 | A |
5645710 | Shieh | Jul 1997 | A |
5656241 | Seifert et al. | Aug 1997 | A |
5704354 | Preidel et al. | Jan 1998 | A |
5720924 | Eikmeier et al. | Feb 1998 | A |
5777060 | Van Antwerp | Jul 1998 | A |
5800350 | Coppleson et al. | Sep 1998 | A |
5810199 | Charlton et al. | Sep 1998 | A |
5814601 | Winslow et al. | Sep 1998 | A |
5849415 | Shalaby et al. | Dec 1998 | A |
5863800 | Eikmeier et al. | Jan 1999 | A |
5900215 | Seifert et al. | May 1999 | A |
5951764 | Hay et al. | Sep 1999 | A |
5971941 | Simons et al. | Oct 1999 | A |
5972199 | Heller et al. | Oct 1999 | A |
5982959 | Hopenfeld | Nov 1999 | A |
5997501 | Gross et al. | Dec 1999 | A |
6004818 | Freilich et al. | Dec 1999 | A |
6036924 | Simons et al. | Mar 2000 | A |
6044665 | Lysson et al. | Apr 2000 | A |
6048352 | Douglas et al. | Apr 2000 | A |
D424696 | Ray et al. | May 2000 | S |
D426638 | Ray et al. | Jun 2000 | S |
6071294 | Simons et al. | Jun 2000 | A |
6071391 | Gotoh et al. | Jun 2000 | A |
6083710 | Heller et al. | Jul 2000 | A |
6099484 | Douglas et al. | Aug 2000 | A |
6103033 | Say et al. | Aug 2000 | A |
6103199 | Bjornson et al. | Aug 2000 | A |
6104940 | Watanabe et al. | Aug 2000 | A |
6107083 | Collins et al. | Aug 2000 | A |
6120676 | Heller et al. | Sep 2000 | A |
6143164 | Heller et al. | Nov 2000 | A |
6241863 | Montbouquette | Jun 2001 | B1 |
6299757 | Feldman et al. | Oct 2001 | B1 |
6329161 | Heller et al. | Dec 2001 | B1 |
6338790 | Feldman et al. | Jan 2002 | B1 |
6349229 | Watanabe et al. | Feb 2002 | B1 |
6375627 | Mauze et al. | Apr 2002 | B1 |
6379317 | Kintzig et al. | Apr 2002 | B1 |
6461496 | Feldman et al. | Oct 2002 | B1 |
6464849 | Say et al. | Oct 2002 | B1 |
6484045 | Holker et al. | Nov 2002 | B1 |
6500144 | Russell et al. | Dec 2002 | B1 |
6503381 | Gotoh et al. | Jan 2003 | B1 |
6560471 | Heller et al. | May 2003 | B1 |
6561989 | Whitson | May 2003 | B2 |
6576101 | Heller et al. | Jun 2003 | B1 |
6576102 | Rappin et al. | Jun 2003 | B1 |
6591125 | Buse et al. | Jul 2003 | B1 |
6592745 | Feldman et al. | Jul 2003 | B1 |
6607658 | Heller et al. | Aug 2003 | B1 |
6610978 | Yin et al. | Aug 2003 | B2 |
6616819 | Liamos et al. | Sep 2003 | B1 |
6618934 | Feldman et al. | Sep 2003 | B1 |
6620112 | Klitmose | Sep 2003 | B2 |
6676816 | Mao et al. | Jan 2004 | B2 |
6706159 | Moerman et al. | Mar 2004 | B2 |
6707554 | Miltner et al. | Mar 2004 | B1 |
6740214 | Dobson et al. | May 2004 | B1 |
6749740 | Liamos et al. | Jun 2004 | B2 |
6783502 | Orloff et al. | Aug 2004 | B2 |
6840912 | Kloepfer et al. | Jan 2005 | B2 |
6881551 | Heller et al. | Apr 2005 | B2 |
6892085 | McIvor et al. | May 2005 | B2 |
6893545 | Gotoh et al. | May 2005 | B2 |
6965791 | Hitchcock et al. | Nov 2005 | B1 |
7008799 | Zimmer et al. | Mar 2006 | B1 |
7058437 | Buse et al. | Jun 2006 | B2 |
7211437 | Schabbach et al. | May 2007 | B2 |
7264139 | Brickwood et al. | Sep 2007 | B2 |
7282705 | Brennen | Oct 2007 | B2 |
7299081 | Mace et al. | Nov 2007 | B2 |
7322942 | Roe | Jan 2008 | B2 |
7335294 | Heller et al. | Feb 2008 | B2 |
7344499 | Prausnitz et al. | Mar 2008 | B1 |
7378007 | Moerman et al. | May 2008 | B2 |
7396334 | Kuhr et al. | Jul 2008 | B2 |
7585278 | Aceti et al. | Sep 2009 | B2 |
7723099 | Miller et al. | May 2010 | B2 |
7740581 | Buse et al. | Jun 2010 | B2 |
7828749 | Douglas et al. | Nov 2010 | B2 |
7829023 | Burke et al. | Nov 2010 | B2 |
7860544 | Say et al. | Dec 2010 | B2 |
8702932 | Say | Apr 2014 | B2 |
8828200 | Marquant et al. | Sep 2014 | B2 |
9044178 | Say | Jun 2015 | B2 |
9459228 | Say | Oct 2016 | B2 |
9746440 | Say | Aug 2017 | B2 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020061589 | King | May 2002 | A1 |
20020098124 | Bentsen et al. | Jul 2002 | A1 |
20030083686 | Freeman et al. | May 2003 | A1 |
20030211619 | Olson et al. | Nov 2003 | A1 |
20040087033 | Schembri | May 2004 | A1 |
20040102717 | Qi | May 2004 | A1 |
20040236251 | Roe et al. | Nov 2004 | A1 |
20050004438 | Ward et al. | Jan 2005 | A1 |
20050023137 | Bhullar et al. | Feb 2005 | A1 |
20050067737 | Rappin et al. | Mar 2005 | A1 |
20050089944 | Shieh et al. | Apr 2005 | A1 |
20050143635 | Kamath et al. | Jun 2005 | A1 |
20050196747 | Stiene | Sep 2005 | A1 |
20050197548 | Dietiker | Sep 2005 | A1 |
20050238537 | Say et al. | Oct 2005 | A1 |
20060241517 | Fowler et al. | Oct 2006 | A1 |
20070027384 | Brister et al. | Feb 2007 | A1 |
20070027385 | Brister et al. | Feb 2007 | A1 |
20070032717 | Brister | Feb 2007 | A1 |
20070093704 | Brister et al. | Apr 2007 | A1 |
20070123803 | Fujiwara et al. | May 2007 | A1 |
20070149897 | Ghesquiere et al. | Jun 2007 | A1 |
20070197889 | Brister et al. | Aug 2007 | A1 |
20070199818 | Petyt et al. | Aug 2007 | A1 |
20070218281 | Demir et al. | Sep 2007 | A1 |
20070261958 | Jiang et al. | Nov 2007 | A1 |
20080017645 | Garagiola | Jan 2008 | A1 |
20080097546 | Powers et al. | Apr 2008 | A1 |
20080167578 | Bryer et al. | Jul 2008 | A1 |
20080275318 | Lastovich | Nov 2008 | A1 |
20080319314 | Hill et al. | Dec 2008 | A1 |
20090021901 | Stothers | Jan 2009 | A1 |
20090032760 | Muscatell | Feb 2009 | A1 |
20090062767 | Van Antwerp et al. | Mar 2009 | A1 |
20090069654 | Yasuzawa et al. | Mar 2009 | A1 |
20090178923 | Marquant | Jul 2009 | A1 |
20090257917 | Nakamura et al. | Oct 2009 | A1 |
20100018869 | Feldman et al. | Jan 2010 | A1 |
20100018871 | Feldman et al. | Jan 2010 | A1 |
20100051479 | Heller et al. | Mar 2010 | A1 |
20100059372 | Heller et al. | Mar 2010 | A1 |
20100059373 | Heller et al. | Mar 2010 | A1 |
20100072063 | Heller et al. | Mar 2010 | A1 |
20100072064 | Heller et al. | Mar 2010 | A1 |
20100326842 | Mazza et al. | Dec 2010 | A1 |
20110028815 | Simpson et al. | Feb 2011 | A1 |
20110086373 | Wallace-Davis et al. | Apr 2011 | A1 |
20110172559 | Fei et al. | Jul 2011 | A1 |
20110180405 | Chinnayelka | Jul 2011 | A1 |
20110189762 | Say | Aug 2011 | A1 |
20110203941 | Say | Aug 2011 | A1 |
20110265944 | Say | Nov 2011 | A1 |
20110266149 | Say | Nov 2011 | A1 |
20110270061 | Say | Nov 2011 | A1 |
20120046533 | Voskanyan et al. | Feb 2012 | A1 |
20120291254 | Say | Nov 2012 | A1 |
20130225957 | Kawamoto | Aug 2013 | A1 |
20140318988 | Say | Oct 2014 | A1 |
20150251174 | Ma | Sep 2015 | A1 |
20170067845 | Say et al. | Mar 2017 | A1 |
20180106750 | Say et al. | Apr 2018 | A1 |
Number | Date | Country |
---|---|---|
2050677 | Mar 1992 | CA |
4105222 | Aug 1992 | DE |
20009392 | Nov 2000 | DE |
10112384 | Sep 2002 | DE |
102004060742 | Jul 2006 | DE |
0 256 415 | Feb 1988 | EP |
0 327 658 | Aug 1989 | EP |
0 409 033 | Jan 1991 | EP |
0 420 296 | Apr 1991 | EP |
0 567 725 | Nov 1993 | EP |
0 592 805 | Apr 1994 | EP |
0 710 835 | May 1996 | EP |
0 792 620 | Sep 1997 | EP |
0 965 301 | Dec 1999 | EP |
1 462 775 | Dec 2007 | EP |
64-3552 | Jan 1989 | JP |
1-153952 | Jun 1989 | JP |
1-263537 | Oct 1989 | JP |
4-279854 | Oct 1992 | JP |
6-174946 | Jun 1994 | JP |
8-107890 | Apr 1996 | JP |
2007-202632 | Aug 2007 | JP |
WO 2012043051 | Apr 2012 | JP |
WO 8907139 | Aug 1989 | WO |
WO 9010861 | Sep 1990 | WO |
WO 9115993 | Oct 1991 | WO |
WO 9410553 | May 1994 | WO |
WO 9606947 | Mar 1996 | WO |
WO 9622730 | Aug 1996 | WO |
WO 9639616 | Dec 1996 | WO |
WO 9715827 | May 1997 | WO |
WO 0035340 | Jun 2000 | WO |
WO 2005051183 | Jun 2005 | WO |
2007037970 | Apr 2007 | WO |
WO 2007091633 | Aug 2007 | WO |
WO 2008017645 | Feb 2008 | WO |
WO 2008118919 | Oct 2008 | WO |
WO 2009032760 | Mar 2009 | WO |
WO 2009051901 | Apr 2009 | WO |
WO 2010056869 | May 2010 | WO |
WO 2010056876 | May 2010 | WO |
WO 2010056878 | May 2010 | WO |
2011003039 | Jan 2011 | WO |
2012043051 | Apr 2012 | WO |
WO 2012106060 | Aug 2012 | WO |
2014025430 | Feb 2014 | WO |
Entry |
---|
European Search Report for 09826755.2 dated Oct. 5, 2012. |
Gough et al., “Short-term In Vivo operation of a glucose sensor,” A.S.A.I.O. Transactions (1986) 32 (1): 148-150. XP000009622. |
International Search Report and Written Opinion for PCT/US2008/074649 dated Apr. 20, 2009. |
International Search Report and Written Opinion for PCT/US2008/074644 dated May 14, 2009. |
International Search Report and Written Opinion for PCT/US2009/064216 dated May 3, 2010. |
International Search Report and Written Opinion for PCT/US2009/064225 dated May 4, 2010. |
International Search Report and Written Opinion for PCT/US2009/064228 dated Jul. 1, 2010. |
Jaraba et al., “NADH amperometric sensor based on poly(3-methylthiophene)-coated cylindrical carbon fiber microelectrodes: application to the enzymatic determination of L-lactate,” Electrochimica Acta. (1998) 43 (23): 3555-3565. |
Netchiporouk et al., “Properties of carbon fibre microelectrodes as a basis for enzyme biosensors,” Analytica Chimica Acta (1995) 303: 275-283. |
Sakslund et al, “Analysis of the factors determining the sensitivity of a miniaturized glucose biosensor made by codeposition of palladium and glucose oxidase onto an 8 μm carbon filter,” Journal of Electroanalytical Chemistry (1996) 402: 149-160. |
Sakslund et al., “Development and evaluation of glucose microsensors based on electrochemical codeposition of ruthenium and glucose oxidase onto carbon fiber microelectrodes,” Journal of Electroanalytical Chemistry (1995) 397: 149-155. |
International Search Report and Written Opinion for PCT/US2013/072846 dated Mar. 26, 2014. |
Chinese Office Action and English translation thereof, Application No. 201380069383.1, dated Aug. 15, 2017, 18 pages. |
European Search Report for corresponding European Patent Application No. 13860026.7, dated Dec. 23, 2016. |
Extended European Search Report for Application No. 15802478.6, dated Feb. 22, 2018. |
Hoey et al., “A Review on Aerosol-Based Direct-Write and Its Applications for Microelectronics,” Journal of Nanotechnology, vol. 2012, Article ID 324380, 22 pages (2012). |
Marinov et al., “Direct-Write Vapor Sensors on FR4 Plastic Substrates,” IEEE Sensors Journal, vol. 7, No. 6, pp. 937-944 (Jun. 2007). |
Young et al., “Future Opportunities for Advancing Glucose Test Device Electronics,” Journal of Diabetes Science and Technology, vol. 5, Issue 5, pp. 1077-1086 (Sep. 2011). |
Zhang, “Printed Electronics: Manufacturing Technologies and Applications Presentation Outline Introduction to Georgia Tech Manufacturing Institute Overview of printed electronics technology and applications Aerosol Jet Printing (AJP) process Application case studies,” 54 pages (May 12, 2014). |
Communication pursuant to Article 94(3) EPC, issued in European Patent Applicatio No. 13860026.7 (dated Aug. 5, 2021). |
Number | Date | Country | |
---|---|---|---|
20150313521 A1 | Nov 2015 | US |
Number | Date | Country | |
---|---|---|---|
61732783 | Dec 2012 | US |